top of page

Leptadenia reticulata, Jivanti: Medicinal Uses, Recipes and Formulations

Nov 15
8 min read

Leptadenia reticulata, commonly known as Jivanti or Jiv, is a perennial climbing shrub of the Asclepiadaceae family whose medicinal value is profoundly centered on its revitalizing, rejuvenating, and lactogenic properties. It is one of the most important herbs in Ayurvedic medicine, described in classical texts as Jivaniya (life-giving), Balya (strength-promoting), and Rasayana (rejuvenative) . The plant's therapeutic profile encompasses galactagogue, antioxidant, immunomodulatory, anti-inflammatory, hepatoprotective, and antidiabetic activities, with traditional applications ranging from respiratory disorders and tuberculosis to wound healing and eye diseases . The whole plant, particularly the leaves and roots, contains a diverse array of bioactive compounds including α-amyrin, β-amyrin, ferulic acid, luteolin, diosmetin, rutin, β-sitosterol, and the unique alkaloids reticulin, deniculatin, and leptaculatin . This comprehensive action on multiple physiological systems, combined with its established role in commercial formulations such as Chyawanprash, Speman, and Leptaden, makes it a uniquely valuable botanical agent . However, a critical appraisal of the evidence reveals that while the classical foundation is strong and preclinical data are promising, clinical efficacy and long-term safety remain significant gaps .


Critical Note on the Evidence Base


A critical caveat must preface this monograph. A 2026 systematized evidence review concluded that the evidence for Jivanti is predominantly preclinical and that current data are insufficient for definitive clinical recommendations . The strongest evidence is its consistent classical documentation and established traditional importance. Phytochemical characterization is moderate, while pharmacological findings remain mainly preclinical. Clinical efficacy, pharmacokinetics, long-term safety, and product interchangeability are major evidence gaps . Most biological studies are restricted to crude extracts, and many biologically active compounds are yet to be identified . This monograph presents the available evidence while clearly distinguishing documented findings from unverified claims.


Medicinal Uses: Summary of Primary and Secondary Actions


Primary Actions


1. Galactagogue and Lactogenic


Leptadenia reticulata is a premier botanical agent for promoting lactation. It is a key ingredient in the commercial Ayurvedic formulation Leptaden, which is used to treat lactation issues including deficiency, irregularity, absence of milk, and poor milk quality . The plant is traditionally known for its lactogenic properties and is used in veterinary practice for the same effect . The mechanism is believed to involve the phytoestrogenic and steroidal compounds that stimulate mammary gland function. A clinical evaluation cited by the manufacturer reports that Leptaden improved milk quality by 11.8 percent, with results proving an improvement in protein, fat, and calcium content in milk without affecting the quantity and regularity of lactation . While this is manufacturer-reported data rather than an independent peer-reviewed trial, it represents the most direct clinical evidence available for this indication.


2. Antioxidant and Immunomodulatory


Jivanti exhibits significant antioxidant and immunomodulatory activity. A study investigating the protective effect of Leptadenia reticulata against chromate-induced immunosuppression in mouse splenic lymphocytes and bone marrow-derived macrophages found that all three extract forms (aqueous extract, Padavashesha kashaya, and Tarpana kashaya) offered protection against immunosuppression, with the aqueous extract showing the superior protective effect . The study confirmed that L. reticulata acts as a modulator and alleviates immunosuppressive conditions. The protective effects were attributed to the presence of triterpenoids including alpha and beta amyrin . The plant is described in ancient Ayurvedic literature as an immune booster and rejuvenator .


3. Anti-inflammatory


Leptadenia reticulata demonstrates anti-inflammatory potential, supported by both traditional use and network pharmacology analysis. A 2024 study employing HR-LCMS/MS analysis identified 113 compounds from the methanolic extract and used network pharmacology to identify hub proteins including CCR2, ICAM1, KIT, MPO, NOS2, and STAT3, which are associated with inflammatory pathways . Molecular docking studies identified various constituents exhibiting high binding affinity scores with these inflammatory targets . The plant is traditionally used for treating inflammation, and its anti-inflammatory potential is attributed to the flavonoids and triterpenoids present .


4. Hepatoprotective


Jivanti has demonstrated hepatoprotective activity in preclinical studies. A study titled "Hepatoprotective activity of Leptadenia reticulata stems against carbon tetrachloride-induced hepatotoxicity in rats" is cited in the evidence review, confirming that the plant has been investigated for its protective effects on liver tissue . The hepatoprotective mechanism is attributed to the antioxidant compounds that scavenge free radicals and reduce oxidative stress in hepatic tissue. The plant is traditionally used for liver-related conditions, and this preclinical evidence provides a rational basis for its use.


5. Antidiabetic


Preclinical evidence supports the antidiabetic potential of Leptadenia reticulata. A 2025 study investigating the ethanolic and aqueous-ethanolic extracts of L. reticulata roots in diabetic models reported significant reductions in fasting blood glucose, HbA1c, and improvements in liver enzymes and creatinine levels . At a dose of 200 milligrams per kilogram, the extract reduced random blood glucose to 98.4 milligrams per deciliter, with HbA1c at 7.6 percent, compared to elevated levels in diabetic controls . The mechanism is attributed to the flavonoids and phenolic compounds that enhance insulin sensitivity and protect pancreatic beta-cells. However, this remains preclinical evidence without human clinical confirmation.


Secondary Actions


1. Antimicrobial and Antibacterial


The plant exhibits antibacterial and antifungal activities, as documented in a comprehensive pharmacological review . The antimicrobial action is linked to the alkaloids, flavonoids, and triterpenoids present in the plant. This activity supports the traditional use of Jivanti for wound healing and infections.


2. Anticancer Potential


Secondary metabolites from Leptadenia reticulata have demonstrated anticancer potential in preclinical studies . The specific compounds and mechanisms are not fully characterized, but this represents an emerging area of investigation. The evidence is preliminary and requires extensive further research.


3. Antiasthmatic and Respiratory Support


The plant is traditionally used for treating respiratory disorders including cough, dyspnea, and tuberculosis . The antiasthmatic activity has been documented in pharmacological reviews . The mechanism is believed to involve the anti-inflammatory and immunomodulatory effects that reduce bronchial inflammation and improve respiratory function.


Critical Safety Warning: Toxicity and Dosage


Leptadenia reticulata is generally regarded as safe when used at traditional therapeutic doses, and the commercial formulation Leptaden is marketed as a natural, non-hormonal, and safe medicine with no side effects . However, this safety claim is based on traditional use and manufacturer assertion rather than rigorous independent toxicological evaluation.


A critical safety consideration is the complete absence of guideline-concordant acute, chronic, genotoxic, and reproductive toxicity studies . The evidence review explicitly identifies nonclinical safety as a major gap requiring completion of guideline-concordant studies . Long-term safety data are entirely lacking. The plant is listed as a threatened endangered species due to overexploitation, unscientific harvesting, and habitat loss, which raises concerns about adulteration and substitution in commercial products . Authenticated botanical material is essential, as the non-availability of genuine planting material is a known challenge .


The use of Leptadenia reticulata during pregnancy requires caution. While the commercial formulation is used as a preventive for women with habitual abortions and high-risk pregnancies , this use should be supervised by a qualified practitioner. The plant has documented anti-implantation activity , which is a paradoxical consideration in the context of pregnancy support. The plant should not be used without professional guidance during pregnancy and lactation, despite its traditional galactagogue use.


Medicinal Parts


The whole plant, leaves, roots, and stems are the primary medicinal parts.


Whole Plant: The Ghana (dried aqueous extract) of the whole plant is used and has been phytochemically evaluated, confirming the presence of flavonoids including quercetin . The whole plant is the source material for the traditional preparations.


Leaves: The leaves contain the bioactive compounds including α-amyrin, β-amyrin, ferulic acid, luteolin, diosmetin, rutin, β-sitosterol, and stigmasterol . The leaves are used in traditional medicine for various ailments.


Roots: The roots have been specifically investigated for antidiabetic activity in preclinical studies . The root extracts demonstrated significant hypoglycemic effects.


Stems: The stems have been investigated for hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity .


Phytochemistry


The pharmacological activity of Leptadenia reticulata is driven by a diverse array of bioactive compounds.


1. Triterpenoids (Whole Plant)


α-Amyrin and β-Amyrin are the primary triterpenoids, along with simiarenol, a triterpene alcohol . These compounds are attributed with anti-inflammatory, antioxidant, and immunomodulatory activities. The protective effects against chromate-induced immunosuppression were attributed to these triterpenoids .


2. Flavonoids and Phenolics (Whole Plant)


Ferulic acid, luteolin, diosmetin, rutin, apigenin, and quercetin are present in the plant . These compounds contribute to the antioxidant, anti-inflammatory, and antidiabetic activities. Quercetin was specifically identified in the dried aqueous extract .


3. Sterols (Whole Plant)


β-Sitosterol and stigmasterol are phytosterols present in the plant . These compounds contribute to the lactogenic and anti-inflammatory effects.


4. Unique Alkaloids (Whole Plant)


Reticulin, deniculatin, and leptaculatin are unique alkaloids identified in Leptadenia reticulata . These compounds are of particular interest for drug discovery and contribute to the plant's distinctive pharmacological profile.


Traditional and Ethnobotanical Uses


1. Lactation Support


Formulation: Leptaden tablet (commercial), whole plant powder.


Preparation and Use: The commercial formulation Leptaden contains Jivanti and Kamboji and is used to treat lactation issues . Traditional preparations involve consuming the whole plant powder or decoction. The plant is used in veterinary practice for its lactogenic effect .


Evidence Basis: Manufacturer-reported clinical data and extensive traditional use. Independent peer-reviewed clinical trials are lacking.


2. Respiratory Disorders


Formulation: Whole plant decoction.


Preparation and Use: The plant is traditionally used for treating tuberculosis, cough, dyspnea, and fever . A decoction of the whole plant is prepared and consumed.


Evidence Basis: Documented traditional use. Preclinical evidence for antiasthmatic and anti-inflammatory activities provides mechanistic support .


3. Wound Healing and Skin Conditions


Formulation: Leaf paste, whole plant decoction.


Preparation and Use: The plant is traditionally used for wounds and skin disorders . A paste of the leaves or a decoction of the whole plant is applied topically.


Evidence Basis: Documented traditional use. The antimicrobial and anti-inflammatory properties support this application.


Clinical Significance and Evidence Summary


1. Evidence Hierarchy by Activity


Galactagogue: Level 3. Manufacturer-reported clinical data and extensive traditional use, but independent peer-reviewed clinical trials are lacking .


Antioxidant and Immunomodulatory: Level 2. In vitro evidence demonstrating protection against chromate-induced immunosuppression .


Anti-inflammatory: Level 2. Network pharmacology and molecular docking evidence identifying inflammatory targets .


Hepatoprotective: Level 2. Preclinical evidence from carbon tetrachloride-induced hepatotoxicity models .


Antidiabetic: Level 2. Preclinical evidence from diabetic animal models demonstrating significant glycemic reductions .


2. Study Limitations and Research Needs


The evidence base for Leptadenia reticulata is characterized by a strong classical foundation and promising preclinical findings, but significant gaps remain. The 2026 evidence review identified the following minimum research priorities: validated chemical standardization methods (HPTLC/HPLC/LC-MS fingerprints), guideline-concordant nonclinical safety studies (acute, chronic, genotoxic, reproductive), pharmacokinetic characterization, indication-specific controlled clinical trials with validated outcomes, and sustainable supply systems linked to quality control . The plant's endangered status also necessitates conservation efforts alongside medicinal development .


Drug Interactions


No specific drug interaction studies have been conducted on Leptadenia reticulata. Given its antidiabetic and immunomodulatory activities, theoretical considerations warrant monitoring.


Potential Additive Hypoglycemic Effect: Preclinical evidence demonstrates antidiabetic activity . Co-administration with insulin or oral hypoglycemic medications may produce additive effects. Blood glucose monitoring is advised.


Potential Immunomodulatory Interactions: The plant demonstrates immunomodulatory activity . Caution is advised in individuals on immunosuppressive therapy.


Final Summary of Contraindications and Precautions


Absolute Contraindications:


· Known allergy to Leptadenia reticulata or other plants in the Asclepiadaceae family.


Use with Caution:


· Pregnancy and breastfeeding: use only under professional supervision despite traditional galactagogue use, due to documented anti-implantation activity and lack of safety data .

· Individuals on antidiabetic medication: monitor blood glucose for potential additive hypoglycemic effects.

· Individuals on immunosuppressive therapy: monitor for potential interactions.

· Use of commercial products: ensure authenticated botanical material due to the plant's endangered status and risk of adulteration .


Disclaimer: This monograph is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare practitioner before using herbal medicines, especially in the context of existing medical conditions or concurrent pharmaceutical treatments. The evidence for Leptadenia reticulata is predominantly preclinical, and clinical efficacy and long-term safety have not been established through rigorous independent trials. The plant is classified as endangered, and sustainable sourcing should be prioritized.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page